E-LIB Suche - Ergebnisse für: Aljumaily, Raid

1

Ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients..:

Patel, Manish R. ; Johnson, Melissa ; Winer, Ira...
Cancer Immunology, Immunotherapy. 73 (2024) 5 - p. , 2024

Link: https://doi.org/10.1007/..

2

Comparing the rate of immunotherapy treatment change due to..:

Chua, Kevin J. ; Kronstedt, Shane ; Kaldany, Alain...
Cancer Reports. 7 (2024) 2 - p. , 2024

Link: https://doi.org/10.1002/..

3

Analysis of Radiation Therapy Quality Assurance in NRG Onco..:

Tchelebi, Leila T. ; Winter, Kathryn A. ; Abrams, Ross A....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 1 - p. 107-114 , 2024

Link: https://doi.org/10.1016/..

4

A Phase Ib Dose-Escalation Study of LCL161 Plus Oral Topote..:

Johnson, Melissa L ; Patel, Manish R ; Aljumaily, Raid...
The Oncologist. 28 (2023) 7 - p. 640-e559 , 2023

Link: https://doi.org/10.1093/..

5

Prognostic impact of natural killer cell recovery on minima..:

Keruakous, Amany R. ; Asch, Adam ; Aljumaily, Raid..
Transplant Immunology. 71 (2022) - p. 101544 , 2022

Link: https://doi.org/10.1016/..

6

Tolerability and antitumor activity of cemiplimab, a human ..:

Moreno, Victor ; Garrido, Pilar ; Papadopoulos, Kyriakos P....
Lung Cancer. 155 (2021) - p. 151-155 , 2021

Link: https://doi.org/10.1016/..

7

Trilaciclib dose selection: an integrated pharmacokinetic a..:

Li, Chao ; Hart, Lowell ; Owonikoko, Taofeek K....
Cancer Chemotherapy and Pharmacology. 87 (2021) 5 - p. 689-700 , 2021

Link: https://doi.org/10.1007/..

8

A Phase 1b Trial of Prexasertib in Combination with Standar..:

Moore, Kathleen N. ; Hong, David S. ; Patel, Manish R....
Targeted Oncology. 16 (2021) 5 - p. 569-589 , 2021

Link: https://doi.org/10.1007/..

9

Pegilodecakin as monotherapy or in combination with anti‐PD..:

Tannir, Nizar M. ; Papadopoulos, Kyriakos P. ; Wong, Deborah J....
International Journal of Cancer. 149 (2021) 2 - p. 403-408 , 2021

Link: https://doi.org/10.1002/..

10

Avelumab as second-line therapy for metastatic, platinum-tr..:

Apolo, Andrea B ; Ellerton, John A ; Infante, Jeffrey R...
Journal for ImmunoTherapy of Cancer. 8 (2020) 2 - p. e001246 , 2020

Link: https://doi.org/10.1136/..

11

Myelopreservation with Trilaciclib in Patients Receiving To..:

Hart, Lowell L. ; Ferrarotto, Renata ; Andric, Zoran G....
Advances in Therapy. 38 (2020) 1 - p. 350-365 , 2020

Link: https://doi.org/10.1007/..

12

Immunologic and tumor responses of pegilodecakin with 5-FU/..:

Hecht, J. Randolph ; Papadopoulos, Kyriakos P. ; Falchook, Gerald S....
Investigational New Drugs. 39 (2020) 1 - p. 182-192 , 2020

Link: https://doi.org/10.1007/..

13

A first-in-human phase 1a study of the bispecific anti-DLL4..:

Jimeno, Antonio ; Moore, Kathleen N. ; Gordon, Michael...
Investigational New Drugs. 37 (2018) 3 - p. 461-472 , 2018

Link: https://doi.org/10.1007/..

14

Cemiplimab (REGN2810), a Fully Human Anti-PD-1 Monoclonal A..:

Papadopoulos, Kyriakos P ; Owonikoko, Taofeek K ; Johnson, Melissa L...
SKIN The Journal of Cutaneous Medicine. 2 (2018) - p. S45 , 2018

Link: https://doi.org/10.25251..

15

Do proton pump inhibitors modulate the efficacy of anti-PD-..:

Mukherjee, Sarbajit ; Ibrahimi, Sami ; Khalid, Bilal...
Journal of Oncology Pharmacy Practice. 25 (2018) 3 - p. 762-764 , 2018

Link: https://doi.org/10.1177/..